US10851110B2

Heterocyclic inhibitors of PTPN11

University of Texas System

Abstract

The present invention relates to compounds which may be useful as inhibitors of PTPN11 for the treatment or prevention of cancer and other PTP-mediated diseases. Disclosed herein are new compounds and compounds based on pyrazolopyrazines and their application as pharmaceuticals for the treatment …

University: University of Texas System
Assignee: Board Of Regents, The University Of Texas System
Inventor: Philip Jones
Priority date: May 31, 2016
Filing date: February 07, 2019
Grant date: December 01, 2020
Publication date: December 01, 2020
Language: en
PDF source: https://patentimages.storage.googleapis.com/37/41/a0/94bfa1e65d8d22/US10851110.pdf
Metadata fetched: August 29, 2026 00:26